CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
163 hedge funds and large institutions have $371M invested in Clovis Oncology, Inc. in 2021 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 46 increasing their positions, 43 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
163
Holders Change
+5
Holders Change %
+3.16%
% of All Funds
2.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
39
Increased
46
Reduced
43
Closed
32
Calls
$19.3M
Puts
$33.8M
Net Calls
-$14.5M
Net Calls Change
-$8.14M
Top Buyers
| 1 |
Millennium Management
New York
|
$15.6M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$53.5M |
| 3 |
BlackRock
New York
|
$54.9M |
| 4 |
Citigroup
New York
|
$4.84M |
| 5 |
Rafferty Asset Management
New York
|
$3.94M |
